PSYCHEMEDICS CORP financial data

Symbol
PMDI on OTC
Location
Acton, MA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2024 - 24 Mar 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 161% % 6.5%
Debt-to-equity 74% % -9.1%
Return On Equity -33% % 34%
Return On Assets -19% % 31%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6,109,502 shares 5.2%
Common Stock, Shares, Outstanding 6,110,000 shares 5.2%
Entity Public Float $14,200,000 USD -36%
Common Stock, Value, Issued $33,000 USD 3.1%
Weighted Average Number of Shares Outstanding, Basic 5,867,000 shares 2.2%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $749,000 USD -35%
Selling and Marketing Expense $2,550,000 USD -15%
General and Administrative Expense $5,695,000 USD -21%
Operating Income (Loss) $1,893,000 USD 35%
Nonoperating Income (Expense) $23,000 USD 96%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $1,916,000 USD 44%
Income Tax Expense (Benefit) $55,000 USD -108%
Net Income (Loss) Attributable to Parent $1,861,000 USD 55%
Earnings Per Share, Basic 0 USD/shares 56%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $1,417,000 USD -28%
Accounts Receivable, after Allowance for Credit Loss, Current $2,500,000 USD -32%
Assets, Current $4,938,000 USD -27%
Property, Plant and Equipment, Net $2,001,000 USD -35%
Operating Lease, Right-of-Use Asset $844,000 USD -54%
Other Assets, Noncurrent $455,000 USD -28%
Assets $8,318,000 USD -33%
Accounts Payable, Current $462,000 USD -39%
Accrued Liabilities, Current $1,560,000 USD -40%
Liabilities, Current $2,711,000 USD -42%
Operating Lease, Liability, Noncurrent $424,000 USD -55%
Liabilities $3,188,000 USD -44%
Accumulated Other Comprehensive Income (Loss), Net of Tax $1,634,000 USD 0%
Retained Earnings (Accumulated Deficit) $18,634,000 USD -11%
Stockholders' Equity Attributable to Parent $5,130,000 USD -23%
Liabilities and Equity $8,318,000 USD -33%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $473,000 USD -110%
Net Cash Provided by (Used in) Financing Activities $75,000 USD -4.2%
Net Cash Provided by (Used in) Investing Activities $5,000 USD
Common Stock, Shares Authorized 50,000,000 shares 0%
Common Stock, Shares, Issued 6,778,000 shares 4.7%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $543,000 USD -47%
Interest Paid, Excluding Capitalized Interest, Operating Activities $4,000 USD -20%
Deferred Tax Assets, Valuation Allowance $2,660,000 USD 3.1%
Deferred Tax Assets, Gross $3,168,000 USD -10%
Operating Lease, Liability $876,000 USD -56%
Payments to Acquire Property, Plant, and Equipment $0 USD -100%
Lessee, Operating Lease, Liability, to be Paid $957,000 USD -54%
Property, Plant and Equipment, Gross $24,167,000 USD -9.5%
Operating Lease, Liability, Current $452,000 USD -57%
Operating Lease, Weighted Average Discount Rate, Percent 3.8 pure -2.6%
Deferred Income Tax Expense (Benefit) $0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $81,000 USD 0%
Deferred Tax Assets, Operating Loss Carryforwards $545,000 USD 526%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 873,000 shares 0%
Operating Lease, Payments $287,000 USD -1.4%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $508,000 USD -46%
Share-based Payment Arrangement, Expense $917,000 USD 0.99%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%